Last update 16 May 2025

Citalopram Hydrobromide/Mecamylamine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
SERT x nAChRα1/β1/δ/γ
Action
antagonists, inhibitors
Mechanism
AChR antagonists(Acetylcholine receptor; alpha1/beta1/delta/gamma antagonists), SERT inhibitors(Serotonin transporter inhibitors)
Therapeutic Areas
Other Diseases
Active Indication-
Inactive Indication
Attention Deficit Disorder With Hyperactivity
Originator Organization
University of South FloridaUniversity of South Florida
Active Organization-
Inactive Organization
Catalyst Biosciences, Inc.Catalyst Biosciences, Inc.Layton BioScience, Inc.University of South FloridaUniversity of South Florida
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC11H22ClN
InChIKeyPKVZBNCYEICAQP-UHFFFAOYSA-N
CAS Registry826-39-1
View All Structures (2)

Related

100 Clinical Results associated with Citalopram Hydrobromide/Mecamylamine Hydrochloride
Login to view more data
100 Translational Medicine associated with Citalopram Hydrobromide/Mecamylamine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Citalopram Hydrobromide/Mecamylamine Hydrochloride
Login to view more data
100 Deals associated with Citalopram Hydrobromide/Mecamylamine Hydrochloride
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Attention Deficit Disorder With HyperactivityPhase 3-
Catalyst Biosciences, Inc.Catalyst Biosciences, Inc.
-
Attention Deficit Disorder With HyperactivityPhase 3-
Layton BioScience, Inc.
-
Attention Deficit Disorder With HyperactivityPhase 3-
University of South FloridaUniversity of South Florida
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free